	US-based Grand River Aseptic Manufacturing (GRAM), a parenteral contract, development, and manufacturing organization (CDMO), has completed a $60-million expansion project in Grand Rapids, MI, and recently began occupancy at the site, the company announced in a June 30, 2020 press release.

	With the expansion completed, the CDMO opened its new large-scale aseptic fill/finish facility in Grand Rapids, which more than triples its existing footprint. The added capacity, updated technologies, and state-of-the-art equipment provide flexible solutions for complex sterile injectables.

	The new facility is part of the GRAM campus and is the third fill/finish facility for the company, giving it more than 100,000 ft2 of dedicated space that features:

		A fully integrated, high-speed Bausch+Ströbel filling line

		SKAN isolators and an IMA lyophilizer auto-loader

		Grade C cleanroom and formulation suites.

Aseptic/Sterile Processing

Cleanroom Equipment and Supplies

Contract Manufacturing, Sterile, Aseptic Processing

Facility Design and Engineering

Fill-Finish

Formulation

Formulation and Drug Delivery, Parenterals

Manufacturing

Manufacturing, Liquid Drug Products

Manufacturing, Parenterals and Injectables

Outsourcing

Parenterals

PharmTech News

Supplier News

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.